MSB 2.17% $1.13 mesoblast limited

Cell Therapy News/Articles, page-8308

  1. 15,110 Posts.
    lightbulb Created with Sketch. 821
    Doubt that Kurt, what price are you hoping to jump in at?, Novartis are committed, they know they are backing a winning horse and revolutionary medical treatments- demand for MSB treatments are going through the ceiling.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.